Management of SAEs involves several steps. Initially, the event is reported to relevant regulatory bodies, such as the FDA in the United States or the EMA in Europe. The regulatory bodies then review the data and may issue safety communications or require changes to the product's labeling. In some cases, they may mandate additional clinical trials or even withdraw the product from the market. Healthcare providers are also advised to follow specific treatment protocols to manage the adverse event effectively.
